Evidence map›Paper›PMID 36574183›Full record

ArticleAIDS and behavior2023

Impact of COVID-19 on Adolescent HIV Prevention and Treatment Services in the AHISA Network.

Charisse V Ahmed, Merrian J Brooks, Stephanie M DeLong, Brian C Zanoni, Irene Njuguna, Kristin Beima-Sofie, Dorothy E Dow, Aisa Shayo, Alana Schreibman, Jennifer Chapman and 4 more

Open access · hybridAbstract read
In one paragraph

Article in AIDS and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 4 countries.

Charisse V AhmedUniversity of Pennsylvania School of Nursing, Philadelphia, PA, USA.
Merrian J BrooksDepartment of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Stephanie M DeLongDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Brian C ZanoniDepartments of Medicine and Pediatric Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Irene NjugunaKenyatta National Hospital, Research and Programs, Nairobi, Kenya.
Kristin Beima-SofieDepartment of Global Health, University of Washington, Seattle, WA, USA.
Dorothy E DowDepartment of Pediatrics, Duke University Medical Center, Durham, NC, USA.
Aisa ShayoKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Alana SchreibmanUniversity of Pennsylvania, Philadelphia, PA, USA.
Jennifer ChapmanChildren's Hospital of Philadelphia Global Health Center, Philadelphia, PA, USA.
Lydia ChenUniversity of Pennsylvania, Philadelphia, PA, USA.
Shreya MehtaUniversity of Pennsylvania, Philadelphia, PA, USA.
Michael T MbizvoPopulation Council, Lusaka, Zambia.
Elizabeth D LowenthalDepartment of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. lowenthale@chop.edu.
University of Pennsylvania · USChildren's Hospital of Philadelphia · USDuke Medical Center · USEmory University · USJohns Hopkins University · USKenyatta National Hospital · KEKilimanjaro Christian Medical Centre · TZNational HIV/AIDS/STI/TB Council · ZMUniversity of Washington · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ronald G Collman · 1999 to 2026
$78.6M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
NIAID NIH HHS P30 AI064518NIAID NIH HHS T32 AI102623
6 · The paper itself

Abstract

We investigated perceived impacts of COVID-19 on the delivery of adolescent HIV treatment and prevention services in sub-Saharan Africa (SSA) by administering a survey to members of the Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA) from February to April 2021. We organized COVID-19 impacts, as perceived by AHISA teams, under three themes: service interruptions, service adjustments, and perceived individual-level health impacts. AHISA teams commonly reported interruptions to prevention programs, diagnostic testing, and access to antiretroviral therapy (ART). Common service adjustments included decentralization of ART refills, expanded multi-month ART distribution, and digital technology use. Perceived individual-level impacts included social isolation, loss to follow-up, food insecurity, poverty, and increases in adolescent pregnancies and sexually transmitted infections. The need for collaboration among stakeholders were commonly cited as lessons learned by AHISA teams. Survey findings highlight the need for implementation science research to evaluate the effects of pandemic-related HIV service adaptations in SSA.

Indexed as

Acquired Immunodeficiency SyndromeCOVID-19HIV InfectionsAdolescentAnti-Retroviral AgentsFemaleHealth Services AccessibilityHumansPregnancyAnti-Retroviral AgentsAfricaCOVID-19HIV preventionHIV treatmentimplementation sciencesurvey

Identifiers

PMID36574183
PMCPMC9792928
OpenAlexW4313257270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.